Should I buy or sell VistaGen Therapeutics stock right now?
1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for VistaGen Therapeutics in the last twelve months. There are curren...
What is VistaGen Therapeutics' stock price forecast for 2022?
1 Wall Street research analysts have issued 12 month price targets for VistaGen Therapeutics' shares. Their forecasts range from $9.00 to $9.00. On...
How has VistaGen Therapeutics' stock price performed in 2022?
VistaGen Therapeutics' stock was trading at $1.95 at the start of the year. Since then, VTGN shares have decreased by 48.7% and is now trading at $...
When is VistaGen Therapeutics' next earnings date?
VistaGen Therapeutics is scheduled to release its next quarterly earnings announcement on Tuesday, July 5th 2022. View our earnings forecast for V...
How were VistaGen Therapeutics' earnings last quarter?
VistaGen Therapeutics, Inc. (NASDAQ:VTGN) posted its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.07) earnings pe...
Who are VistaGen Therapeutics' key executives?
VistaGen Therapeutics' management team includes the following people: Mr. Shawn K. Singh J.D. , CEO & Director (Age 59, Pay $844.66k) Dr. H. Ral...
Who are some of VistaGen Therapeutics' key competitors?
Some companies that are related to VistaGen Therapeutics include Morphic (MORF) , Amylyx Pharmaceuticals (AMLX) , I-Mab (IMAB) , Avid Bioservic...
What other stocks do shareholders of VistaGen Therapeutics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other VistaGen Therapeutics investors own include Highpower Inte...
What is VistaGen Therapeutics' stock symbol?
VistaGen Therapeutics trades on the NASDAQ under the ticker symbol "VTGN."
About VistaGen Therapeutics
Headlines
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing and commercializing new generation medications that go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders.
VistaGen Therapeutics (NASDAQ:VTGN) Frequently Asked Questions
What Kind Of Investors Own Most Of VistaGen Therapeutics, Inc. (NASDAQ:VTGN)?
What is VistaGen Therapeutics?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for VistaGen Therapeutics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" VistaGen Therapeutics stock. View analyst ratings for VistaGen Therapeutics or view top-rated stocks.
What time do you trade in the pre market?
VistaGen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of a major depressive disorder in patients with an inadequate response to standard anti
What time does Old Dominion stock trade?
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Stock prices may also move more quickly in this environment.
Does market cap include convertible securities?
Old Dominion Freight Line, Inc. Common Stock. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4 :00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices.
